Argus initiated coverage of Novo Nordisk with a Buy rating and $110 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVO:
- LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns?
- Craig-Hallum upgrades WW to Hold amid enthusiasm for GLP-1 medications
- Novo Nordisk price target raised to DKK 700 from DKK 685 at Morgan Stanley
- Novo Nordisk, Valo collaborate to develop treatments using human data, AI
- Weight-loss drugs are bad news for medtech makers, Barron’s says